Oesophageal adenocarcinoma is the most common type of oesophageal cancer and is associated with long-term gastro-oesophageal reflux disease (GORD), also known as chronic heartburn or acid reflux.
This blood test measures specific protein biomarkers and combines these results with clinical information to provide an individualised assessment of oesophageal cancer risk.
This test may be suitable for adults who:
Your doctor can advise whether this test is appropriate for you.
Many people with oesophageal cancer are not diagnosed until the disease has progressed to later stages. Current assessment methods typically involve endoscopy, which can be invasive and costly.
This blood test provides a simple, non-invasive approach to assessing oesophageal cancer risk and may provide additional information to support discussions with your healthcare provider.
The test analyses four protein biomarkers associated with oesophageal adenocarcinoma and combines these results with information including age, sex, height and weight to generate a personalised risk score.
A simple blood test is required. You can have the test at any TML Pathology collection centre. Your sample is analysed in an accredited Australian laboratory.
Results are provided to your referring healthcare practitioner.